Commentary on Bevacizumab in Ovarian Cancer: Focus on Clinical Data and Future Perspectives

Vanda Salutari, Giovanni Scambia
2016 Gynecology & Obstetrics  
The established standard strategy for treatment of advanced Epithelial Ovarian Cancer (EOC), has been debulking surgery and platinum/taxane-based chemotherapy followed by surveillance for potential recurrence. Despite initial chemo-sensitivity to platinum/ taxane doublets, most patients with advanced EOC relapse after firstline therapy and global mortality remains high.
doi:10.4172/2161-0932.s5:03 fatcat:js2dl3hevfhrjnl72i3fsmlib4